Patent Terms Extended Under 35 U.S.C.   156

  Certificates extending the terms of the following patents were issued
on January 6, 1997.

U.S. Patent No. 4,250,334; Granted: February 10, 1981, to Clifford L.
Coon, et al; Owner of Record: Baxter International, Inc; Title: Method
of Synthesizing Fluoromethylhexafluoroisopropyl Ether; Classification:
568/683; Product Trade Name: ULTANEĖtm; Original Expiration Date:
December 26, 1999; Term Extended: Five Years; Extended Expiration Date:
December 26, 2004.

U.S. Patent No. 4,376,858; Granted: March 15, 1983, to Norman L. Colbry;
Owner of Record: Warner Lambert Company; Title: 2-4
Diamino-5-methyl-6-[(3,4,5-Trimethoxyanilino) Methyl]Quinazoline Salts;
Classification: 544/291; Product Trade Name: NEUTREXINĖtm; Original
Expiration Date: October 31, 2000; Term Extended: 1,286 days; Extended
Expiration Date: May 9, 2004.

U.S. Patent No. 4,628,098; Granted: December 9, 1986 to Akira Nohara et
al.; Owner of Record: Takeda Chemical Industries Ltd.; Title:
2-[2-Pyridylmethylthio-(Sulfinyl)]Benzimidazoles; Classification:
546/273.7; Product Trade Name: PREVACIDĖtm (lansoprazole); Original
Expiration Date: July 29, 2005; Term Extended: 1,381 days; Extended
Expiration Date: May 10, 2009.

U.S. Patent No. 5,070,877; Granted December 10, 1991, to Syed M.
Mohiuddin et al.; Owner of Record: Medco Research Inc.; Title: Novel
Method of Myocardial Imaging; Classification: 128/653.4; Product Trade
Name: ADENOSCANĖrm; Original Expiration Date: December 10, 2008; Term
Extended: 159 days; Extended Expiration Date: May 18, 2009.